Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major ...

Mary started drinking regularly in the early nineties, when she was thirteen. Her father had recently married a Danish woman and moved the family to Denmark, which has one of the highest teen-drinking ...

Overdose deaths declined significantly in Oklahoma. Researchers say fewer people are dying, in part, due to Medicaid ...

(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...

Mindfulness, holistic care, and neuroscience are reshaping addiction treatment and offering hope for recovery. Mindfulness, holistic care, and neuroscience are reshaping addiction treatment and ...

Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.

Researchers from the University of California San Diego have found that Mindfulness-Oriented Recovery Enhancement (MORE) can help rewire the brain’s response to natural healthy pleasure, leading to ...

A Rutgers-led study found that genes related to impulse control and reward processing are major factors in addiction risk. Researchers analyzed genetic data from over 2.2 million people to understand ...

A growing movement claims social media is “addictive,” and lawmakers are treating it as settled science. But the evidence is ...

Researchers found that buprenorphine for opioid use disorder treatment during pregnancy was linked to better outcomes for newborns than methadone and to similar outcomes for 8-year-olds.

The roots of addiction risk may lie in how young brains function long before substance use begins, according to a new study from Weill Cornell Medicine. The investigators found that children with a ...